CNTX · Context Therapeutics Inc. · Executive Compensation
$0.24
+0.00 (+1.57%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$21.99M
Shares
91.88M
Volume · Oct 23
1.49M
Avg daily vol (3M)
1.55M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $1,465,430 |
| Jennifer Minai-Azary | Chief Financial Officer and Treasurer | $866,139 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $816,671 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $1,011,069 |
| Jennifer Minai-Azary | Chief Financial Officer | $698,968 |
| Alex Levit | Chief Legal Officer | $670,653 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $860,681 |
| Jennifer Minai-Azary | Chief Financial Officer | $606,676 |
| Alex Levit | Chief Legal Officer | $582,148 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $1,057,653 |
| Jennifer Minai-Azary | Chief Financial Officer | $680,668 |
| Alex Levit | Chief Legal Officer | $653,100 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $1,587,791 |
| Alex Levit | Chief Legal Officer | $596,709 |
| Jennifer Minai-Azary | Chief Financial Officer | $322,175 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | Chief Executive Officer | $250,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Andy Pasternak | Chairperson of the Board | Appointed | 2025-01-13 |
| Richard Berman | Board of Directors | Resigned | 2025-01-13 |
| Dr. Luke Walker | member of the Board | Appointed | 2024-09-04 |
| Dr. Karen L. Smith | member of the Board | Appointed | 2024-09-04 |
Leadership
- Martin Lehr CEO, Board Member
- Andy Pasternak Chairman, Board Member
- Jennifer Minai-Azary CFO
- Dr. Karen L. Smith Board Member
- Dr. Luke Walker Board Member
- Jennifer Evans Stacey Board Member
- Karen Smith Board Member
- Linda West Board Member
- Luke Walker Board Member
- Philip Kantoff Board Member
Key facts
CIK
1842952
CUSIP
21077P108
13F (30d)
11 filings
11 filers
Visit website
Investor relations